SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-280742
Filing Date
2023-11-20
Accepted
2023-11-20 17:01:30
Documents
12
Period of Report
2023-10-31
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K/A d392219d8ka.htm   iXBRL 8-K/A 26435
  Complete submission text file 0001193125-23-280742.txt   152984

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nexi-20231031.xsd EX-101.SCH 2827
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20231031_lab.xml EX-101.LAB 18686
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20231031_pre.xml EX-101.PRE 11677
6 EXTRACTED XBRL INSTANCE DOCUMENT d392219d8ka_htm.xml XML 3878
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40045 | Film No.: 231423478
SIC: 2834 Pharmaceutical Preparations